Device Sports Med Hip

The Pink Hip Kit - Smith & Nephew Table

Payments companies reported to CMS as associated with The Pink Hip Kit - Smith & Nephew Table. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$129Kassociated payments (2023-2025)
121clinicians with associated payments
1company reporting

By year

2023 $11K
2024 $90K
2025 $28K

Payments reported as associated with The Pink Hip Kit - Smith & Nephew Table, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $66K
Sports Medicine (Orthopaedic Surgery) $56K
Adult Reconstructive Orthopaedic Surgery $3,161
Pediatric Orthopaedic Surgery $2,073
Pediatric Otolaryngology $809
Physician Assistant $56.78

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with The Pink Hip Kit - Smith & Nephew Table

These are the largest totals companies reported as associated with The Pink Hip Kit - Smith & Nephew Table. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Christopher Larson Edina, MN Orthopaedic Surgery $12,423.63
Brian White Englewood, CO Sports Medicine (Orthopaedic Surgery) $10,431.53
Kenneth Weeks Charlotte, NC Orthopaedic Surgery $9,435.00
Yi Meng Yen Boston, MA Sports Medicine (Orthopaedic Surgery) $4,956.25
Bojan Zoric Peabody, MA Sports Medicine (Orthopaedic Surgery) $4,575.00
Robert Westermann Iowa City, IA Orthopaedic Surgery $4,311.68
Matthew Mai Fort Walton Beach, FL Orthopaedic Surgery $3,160.00
Michael Banffy Los Angeles, CA Sports Medicine (Orthopaedic Surgery) $3,160.00
Samuel Willimon Atlanta, GA Orthopaedic Surgery $2,761.68
Gary Okamura Honolulu, HI Orthopaedic Surgery $2,661.20

Prescribed The Pink Hip Kit - Smith & Nephew Table?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.